YC
PNT

Yarbrough Capital’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Yarbrough Capital’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-42,130
Closed -$281K – 210
2023
Q3 		$281K Hold
42,130
– – 0.02% 181
2023
Q2 		$382K Buy
+42,130
New +$372K 0.02% 158

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Yarbrough Capital's PNT Position: Q4 2023 in Review

Yarbrough Capital sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 42,130 shares — an estimated $281K sold.

Yarbrough Capital first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $382K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Yarbrough Capital reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Yarbrough Capital sold 42,130 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $281K.
  • Yarbrough Capital first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Yarbrough Capital's POINT Biopharma Global Inc. Common Stock position peaked at $382K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Yarbrough Capital's 13F filing for Q4 2023, filed 12 Jan 2024.